# A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea

> **NCT03564119** · PHASE3 · COMPLETED · sponsor: **Sol-Gel Technologies, Ltd.** · enrollment: 372 (actual)

## Conditions studied

- Papulopustular Rosacea

## Interventions

- **DRUG:** S5G4T-1
- **DRUG:** S5G4T-2

## Key facts

- **NCT ID:** NCT03564119
- **Lead sponsor:** Sol-Gel Technologies, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-21
- **Primary completion:** 2019-06-10
- **Final completion:** 2019-06-10
- **Target enrollment:** 372 (ACTUAL)
- **Last updated:** 2021-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03564119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03564119, "A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT03564119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*